Cipla in talks with Eli Lilly for diabetes drug, say sources; shares in green
Cipla share price news, Cipla-Eli Lilly News: Cipla is in talks with US-based Eli Lilly to manufacturer Semaglutide and Ozempic — anti-diabetic medications — in India, sources told Zee Business. The Cipla stock held on firmly to the green after the news. Initially, Eli Lilly will share technology with Cipla, which will later produce these…